Your position:
m.limatoxi.com
>>
EN
>>
EN
>>
Formulation
>>
Luoqi Biotech LQ043H single-domain antibody nebulizer was approved for clinical trials
>> article
Luoqi Biotech LQ043H single-domain antibody nebulizer was approved for clinical trials
Editor:xuezhe Clicks:
0
Date:2023-1-12 13:49:54
Keyword:
Luoqi Biotech LQ043H
Healthoo Information:
Luoqi Biotech LQ043H single-domain antibody nebulizer was approved for clinical trials
UserLogin
UserName：
Password：
The non-formal user may read the summary, the formal user can read the whole article。
please at once register the user of Heatlhoo.com
After registration, we will provide the sample reports and the more comprehensive consulting services for you.
UserName
Contact:
Title:
Mr.
Ms.
Password
Repeat password:
Mobile
Email
Verification code:
Company Name
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
Top Biotechnology Financing List Released! Two Chinese Pharmaceutical ...
VC price from main domestic suppliers
Vitamin C export statistics in first hal...
Taiwan eyes biotech cooperation with China
Gaoke Vitamin C item passed environmental&nbs...
Tiger Biotech to build the project of&nb...
Tiger Biotech to expand vitamin C capaci...
Shanghai makes large investment into biotechn...
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463
map
